Advanced Search
Contact | Corporate | Help

Daily news email for May 15, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

 b3c newswire
Vetter Boosts Quality and Logistic Processes

Definiens Expands Functionality of Its Leading Solution for Quantitative Digital Pathology with ...

Antisense Pharma Internationalizes Management Board

Mucosis Announces Positive Proof-Of-Concept Data for Mimopath® Platform In Humans

Nuevolution Announces Receipt of Milestone Payment from Boehringer Ingelheim

 BioSpace
Achillion Pharmaceuticals, Inc.'s Hepatitis C Drug Gets FDA Fast Track

Gamida Cell Ltd. Raises $10 Million to Progress Phase III-Stage Hematologic Cancer Cell Therapy

How Payers View Pfizer Inc.'s Rheumatoid Arthritis Pill

Cross-Reactivity Between Peanuts and Other Legumes Can Lead to Serious Allergic Reactions, Norwegian School of Veterinary Science Study

A Little More Education, a Little Longer Life Study

BioSpace - Breaking News
Merck KGaA Profit Down on Liquid Crystal Rivalry

Aeolus Pharmaceuticals Inc. Announces Second Quarter Fiscal Year 2012 Financial Results

Helix Biopharma Commences Polish Phase I/II Clinical Study of Its Lung Cancer Drug Candidate L-DOS47

Promedior Moves Fibrosis Pipeline to Boston, Hires Shire plc Vet as CEO

Scil Proteins GmbH, Ono Pharmaceutical Company, Ltd. Establish Affilin Therapeutics Discovery and Development Collaboration

Biotech News - Business Wire
Samenvatting: Jim Cunniff benoemd tot Senior Vice President voor KCI van Amerikaanse continent

BIO to Testify at Congressional Hearing on 2012 Farm Bill Energy Programs

Greatbatch, Inc. to Participate in the Bank of America Merrill Lynch 2012 Health Care Conference

The Next Wave of Growth for Managed Care Organizations Will Come from Dual-Eligibles

Medtronic Announces 2012 Analyst Meeting and Webcast

 Biotech News - PR Newswire
IntelligentMDx Announces CE-Marking of a new high-throughput test for Group B Streptococcus intended to improve women's health and prenatal care

Angiotech Announces Financial Results for the First Quarter Ended March 31, 2012

Cardium Presents First Quarter 2012 Financial Results and Recent Developments

Generex Enhances Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine with Renowned Breast Cancer Researchers

Frost & Sullivan Research Preview: Top 20 Telehealth Markets
Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

 Burrill Report
Blech, One-Time "King of Biotech," Pleaded Guilty to Manipulating Stock Prices

Gilead's Truvada Gains Support for HIV Prevention

Daiichi Sankyo Enters Biosimilars Arena with Coherus BioSciences

Groups Weigh in on Biosimilars

Vertex's Cystic Fibrosis Considered Game-Changer

 CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure
Clinical Trials - Business Wire
CEL-SCI's Chief Scientific Officer Presents at Cancer Symposium

Elixir Medical Announces Continued Excellent One Year Safety and Efficacy Data from the EXCELLA BD Randomized Clinical Trial for DESyne BD Novolimus Eluting Coronary Stent with Biodegradable Polymer

Todd Campbell Appointed Vice President of Operations of ValveXchange, Inc.

Reocor

Svelte Medical Systems Announces Final Patient Treated in the DIRECT Drug-Eluting Stent Study

 Clinical Trials - PR Newswire
Boston Scientific Announces Positive Data From Lotus Transcatheter Aortic Valve Trial

GeoVax Labs Reports 2012 First Quarter Financial Results

AXIOS Stent and Delivery System Study Demonstrates Successful Treatment of Pancreatic Pseudocysts and Acute Cholecystitis

SPARTAN MEDICAL Reports Milestone

Telik Announces the Publication of Two Reports in the Journal Of Hematology & Oncology Describing the Results of a Clinical Study of Telintra® in Combination With Revlimid® and a Genomic Study Designed to Identify Genes That Predict Response to Teli

 CNN Top Stories
Who's using mobile maps Who's not

5 bodies found after Florida standoff

Greek talks end, no deal on government

Rushkoff: Will Facebook lose its edge

Murdoch aide charged in hacking probe
Contract Pharma
BMS, Tsinghua U in Bio-Discovery Pact

Aptiv Solutions Appoints Chief Commercial Officer

Sygnature, Pneumolabs in Discovery Service Pact

Molecular Profiles, GEA in Early Screening Pact

Almac Adds Blistering Equipment at US HQ

 FDA Drugs- What's New
FDA Drug Safety Communication: Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod)

FDA Drug Safety Communication: Safety review update of cancer drug Revlimid (lenalidomide) and risk of developing new types of malignancies

Comunicado de la FDA sobre la seguridad de los medicamentos: Información actualizada sobre la interacción entre el medicamento Victrelis (boceprevir) y ciertos medicamentos reforzados inhibidores de la proteasa del VIH

Comunicado de la FDA sobre la seguridad de los medicamentos: Información actualizada sobre la interacción entre el medicamento Victrelis (boceprevir) y ciertos medicamentos reforzados inhibidores de la proteasa del VIH

Comunicado de la FDA sobre la seguridad de los medicamentos: Nueva advertencia y contraindicación sobre medicamentos para la presión arterial que contienen aliskiren

 FDA News - Business Wire
U.S. FDA Approves Bristol-Myers Squibb Devens Biologics Manufacturing Facility for Production of ORENCIA® (abatacept)

Beech Tree Labs Announces William J. Ryan's Appointment to Board of Directors

Furiex Pharmaceuticals Announces Agreement to Transfer Priligy® Product Rights

Furiex Pharmaceuticals and Menarini Announce License Agreement for Priligy®

SANUWAVE Reports First Quarter Financial Results
FDA Press Releases
FDA issues alert on potential dangers of unproven treatment for multiple sclerosis

FDA proposal aims to help reduce unnecessary radiation exposure for children

FDA issues final rule on sterility testing of biological products

FDA permits marketing of a new device for abdominal surgery

FDA approves new orphan drug to treat a form of Gaucher disease

 FDA Vaccines, Blood and Biologics - What's New
Moon Marine USA Corporation voluntarily recalls frozen raw yellowfin tuna product Nakaochi Scrape associated with a multistate outbreak of Salmonella Bareilly infections

Multi-Center Fellowship in Regenerative Medicine

FDA Webinar on Safety of the Blood Supply

WinRho SDF Liquid

Flebogamma DIF 5%

 FierceBiotech
Newron soars on positive PhIII results, $26M pact for Parkinson's drug

First wave of AstraZeneca's CNS R&D group gets the ax

New chief takes helm at Promedior and steers a course for Boston

Buzz: Big Pharma suitors line up for a look at Amylin's books

Download our eBook 'Supplying global clinical trials: Keys to avoiding costly delays'
FierceBiotech IT
Mobile apps could rival pharma's crown jewels

UPDATED: AstraZeneca leans on IT to transform an ailing business

UPDATED: BioClinica chief touts Microsoft ties in Q1 report

Join a live Twitter chat with Medidata's Glen de Vries

Boehringer, pharmas turn to social gaming for online outreach

 FierceBiotech Research
Scientist uses stem cells to rebuild bone

How do you make a deaf mouse hear Emory University tries gene therapy

Compounds may combat cancers by reversing p53 mutation

Preclinical breakthrough: Scientists beat rare skin cancer tumors

Researchers cure Type 1 diabetes in mice

 FiercePharma
Big-name pharmas peer at Amylin's books to prep for bids

Payers likely to throw up hurdles to Pfizer's new RA drug

Clinical trials to size up antipsychotics like Seroquel for PTSD

Eisai broadens marketing deal for Arena's weight-loss drug

Sales-needy Takeda springs for emerging markets growth
FiercePharma Manufacturing
Pakistan's ephedrine scandal takes on international intrigue

Merck KGaA says cuts will save $385 million

Another pain drug recall for Hospira

U.K. pharmacy group wants drug exports stopped

Contract manufacturer Vetter to open new high-tech warehouse

 FierceVaccines
UPDATED: Teen meningitis B vax successful in Phase II

MMR and autism: Italy's courts get involved

Pneumococcal vax cuts deaths, but cases tripled

First 'cross-kingdom' vax effective in PhI

Study: Further insight into Merck HIV vax infection increase

 Health News - BizJournals.com
Cardinal Health to suspend narcotics shipments for 2 years from Fla. warehouse

Wrinkle treatment maker Fibrocell raises $3M

PrimBio, CropLord newest Science Center tenants

UTHSC viral disease researcher lands $1.1M grant

Medical billing website Simplee nabs $6M venture capital infusion

Health News - CNBC
Roche Alzheimer's drug picked for major test

Romney Medicare Plan Draws a Stark Contrast

Walgreen adds benefits to customer savings club

Retiree Money Scams Flourish, Change With the Times

Cardinal facility suspended under DEA settlement

 Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

 Inside Industry - Gen
Six Suitors Join Bristol-Myers in Considering a Bid for Amylin

New UMass Accelerator to Focus on Growing Biomanufacturing

GSK, HGS Saddle Up for Acquisition Battle Valuing HGS at $2.6B

NCCN Foundation Announces 2012 Young Investigator Awards

GEN Poll Respondents 'somewhat Optimistic VC Market Will Improve This Year
Marketwire - Pharma and Biotech
Reimbursement Intelligence: Tofacitinib to Be Positioned After Anti-TNFs, Say Payers Based on FDA Panel Review

Cadus Reports First Quarter 2012 Results

MedForum12 Brings Top Minds in Healthcare Together to Explore Value-Based Solutions for the U.S. Healthcare System

Agile Therapeutics President and Chief Executive Officer Al Altomari Is an Ernst & Young Entrepreneur Of The Year(R) 2012 Finalist in New Jersey

Evogene Reports First Quarter 2012 Financial Results

 MassBio News
MassBio Honored with NORD's Power of Partnership Award

10 reasons to attend the BIO International Convention

New Therapy Helps Patients Soar to New Heights

BIO 2012 Massachusetts Pavillion Patient Profiles

By Popular Demand: New Professional Development Courses Aim to Meet Industry Needs

 Medical Pharma - PR Newswire
Sentry Partners with Hospitals in Alliance to Protect 340B

Alzheimer's Association Applauds The Creation Of The First National Alzheimer's Plan

Warm Weather Means Active Children May Be Prone To More Injuries

Oxford Finance Acts as Syndication Agent and Lender for Senior Credit Facility Used to Acquire SeraCare Life Sciences

New Donning Device For Compression Garments Now Available In The US
National Center for Biotechnology Information
GTR News

GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

PubMed Health Featured Reviews

 Nature Biotechnology
High-efficiency TALEN-based gene editing produces disease-resistant rice

Recasting natural product research

A work in progress

Drug pipeline: 1Q12

Biotech equities heat up in 1Q12

 New York Times- Biotechnology
DEALBOOK; Human Genome Sciences Rejects A $2.59 Billion Bid From Glaxo

White House Promotes a Bioeconomy

George Rathmann, Chief of Amgen, Dies at 84

Cost of Gene Sequencing Falls, Raising Hopes for Medical Advances

Cancer Center, in Suit, Claims Ex-Official Took Research
New York Times- Pharmaceuticals
Taking Truvada to Prevent H.I.V. Also Comes With Risks

D.S.M. Revisions May Sharply Increase Addiction Diagnoses

Dialysis Rule Changes Followed by Transfusion Increases

F.D.A. Panel Backs Preventive Use of H.I.V. Drug Truvada

Diet Drug Wins Approval of F.D.A. Advisers

 OnBioVC
ImmuneXcite, Inc.: Series A $2.4M

AirXpanders, Inc.: Series D $10.3M

MC10, Inc.: Series B $2M

CN Creative, Ltd.: Series A $3.1M

SEA Medical Systems, Inc.: Series B $3M

 Outsourcing-Pharma
Patheon launches CMC consultancy in face of restructuring plans

SGS adds formulation development services and expands US lab

Once a friend now an enemy: Over zealous EU regulators could hamper the CMO market, says analyst

Pharmas must give patients voice says DIA Europe director

Improve patient compliance by designing trials around real life, says expert
Pharma News - Business Wire
ABMC Reports First Quarter 2012 Results

Research and Markets: Nausea - Pipeline Review, H1 2012 - A Snapshot of the Global Therapeutic Scenario for Nausea

Hospitals Launch Program to Prevent Pressure Ulcers as a Part of Federal Initiative

Walgreens Launches New and Improved Prescription Savings Club as Approximately 1 in 4 U.S. Adults Lack Adequate Prescription Drug Coverage

Theraclone Sciences Announces Positive Top-line Data from a Phase 1 Trial of its Therapeutic Antibody Directed at Influenza A

 Pharma News - PharmiWeb
Cape Cod Healthcare selects Courion to automate identity and access risk management

H.E.R. Foundation Seeks Federal and Private Funding for Research on Hyperemesis Gravidarum

Donated Medical Devices Urgently Needed for Syrian Relief Effort

Lands' End and SELF Magazine Launch Second-Annual National Swimsuit Confidence Week

Raising Women's Voices launches "MamaCare" educational campaign for National Women's Health Week

 Pharma News - PR Newswire
INTAC Technology Combats Misuse of Extended Release Drugs

Cardium Announces Agreement With UK-Based Angel Biomedical For Excellagen Supply And Planned European Market Expansion

Medicalbillersandcoders.com the Market Leader in Placing Certified Medical Coders in New Mexico

PneumRx, Inc. recebe aprovação da FDA para iniciar ensaio clínico pivot do Sistema RePneu de mola para redução volumétrica pulmonar (RePneu LVRC)

TPI Reports Third Quarter Fiscal Year 2012 Financial Results
Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

 PR Leap - Biotech
SHEL LAB Introduces the Bactrox Chamber

Abcam Launches Potent, Novel Dynamin Inhibitor Licensed from the University of Newcastle and Children's Medical Research Institute

Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

Ascent Scientific Launch Novel Dynamin Inhibitor Dyngo-4a™ with Children's Medical Research Institute and University of Newcastle

 PRWeb - Biotechnology
Entrepreneurial Movement Startup Canada is coming to ventureLAB in...

ADIENNE Pharma & Biotech Signs Service Agreement with Selexis for...

LinkedIn and MD247 Tackle Telemedicine

WITI Announces 2012 Hall of Fame Award Honorees: Dr. Genevieve Bell;...

EAG Coatings Solutions Strengthens Management Team with Addition of...
PRWeb - Pharmaceuticals
World Vets and Innovacyn Partner For Pilot Mission To Tanzania

Healthcare Solutions Releases 2012 Drug Trends Report

San Jose Marijuana Cooperative MedMar Healing Center Gives Back to the...

National Pain Institute Now Offering Treatment with Board Certified...

AbilityCRM Enters Top 1% with Microsoft Gold CRM Competency

 Scientific American
Not-So-Quick Fix: ADHD Behavioral Therapy May Be More Effective Than Drugs in Long Run

In Search of the Best (Energy) Ideas: A Q&A with ARPA-E's Arun Majumdar

In Search of the Best (Energy) Ideas: A Q&A with ARPA E's Arun Majumdar

Ancient Time: Earliest Mayan Astronomical Calendar Unearthed in Guatemala Ruins

Climate Forecasting: A Break in the Clouds

 Sports - ESPN Basketball
Selection committee chair named AD at Hofstra

Morehead St. makes MVSU's Woods new coach

Texas PG Gibbs officially transfers to Seton Hall

Old Dominion board to discuss CAA affiliation

UNC-Indiana highlights ACC-Big Ten Challenge
Sports News - ESPN
NFL, NCAA donating to youth helmet initiative

Monk, Casper lead college football HOF class

Idaho WR McRoyal fatally shot in Los Angeles

Commission hands control of Coliseum to USC

QB Forcier says he signed with CFL's Hamilton

 Xconomy Life Sciences
Theraclone Passes First Clinical Test with Flu-Fighting Antibody

Promedior Moves Fibrosis Pipeline to Boston, Hires Shire Vet as CEO

Coaching Program Springboard Hits Boston With Life Sciences Entrepreneurs

Five Questions for E&Y's David DeMarco on the Future of Health IT

JumpStart, NEI Plan New High Tech Accelerator in Detroit

 Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)


SourceSolution © 2008-2012